# AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

> **NCT00265876** · PHASE1,PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 34 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** AZD0530
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00265876
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04-26
- **Primary completion:** 2009-01-08
- **Final completion:** 2012-01-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265876, "AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00265876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*